Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Lymphoma 4Sleep Initiation and Maintenance Disorders 2Multiple Myeloma 2Lymphoma, Follicular 2Glioblastoma 2Fatigue 2Anxiety Disorders 2Uterine Neoplasms 1Sleep Wake Disorders 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasms 1Meningioma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Glioma 1Generalized Anxiety Disorder 1Esophageal Neoplasms 1Depression 1Brain Neoplasms 1Astrocytoma 1

Interventions

Psychiatric Rehabilitation 2Bortezomib 2trametinib 1sonidegib 1ribociclib 1entinostat 1carboxyamido-triazole 1Vorinostat 1Thalidomide 1Temozolomide 1Paclitaxel 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Gelclair 1Filgrastim 1Fentanyl 1Docetaxel 1Cognitive Behavioral Therapy 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningioma × Cognitive Behavioral Therapy × Lymphoid × Clear all
NCT06439420 2025-10-01

CBT-I in PBT

Virginia Commonwealth University

Phase 2 Completed
70 enrolled
CNSLymphoid

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Sleep Initiation and Maintenance Disorders, Lymphoma, Meningioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡